Urinary Continence After Vaginal Surgery for Genital Prolapse in the Spanish Population.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-99
SponsorHospital Universitari Vall d'Hebron Research Institute

About this trial

Surgical correction of pelvic organ prolapse (POP) may be associated with the development of postoperative stress urinary incontinence (SUI). This clearly affects women's satisfaction and their quality of life, and may require subsequent medical and/or surgical treatments.

On the other hand, pre-existing SUI could resolve after corrective prolapse surgery. Similarly, urge urinary incontinence (UUI) could appear or improve after vaginal POP surgery. Therefore, it is of paramount importance to know the prevalence of urinary incontinence after POP vaginal surgery and incontinence resolution in our population. Identifying the risk factors for the development of urinary incontinence may allow to provide individualized treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women who will undergo vaginal surgery for pelvic organ prolapse

Disqualifiers

inhability to give consent to the study

Trial population

Women referred to different Spanish hospitals for symptomatic pelvic organ prolapse who are candidates for surgical correction of their POP.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Vaginal surgery for pelvic organ prolapse

    Procedure/Surgery

    Vaginal surgery of any vaginal compartment for pelvic organ prolapse

Treatment groups

1,042 Participants
are divided into 1 treatment group
Group A: Women with pelvic organ prolapse who are candidates for vaginal surgery for its correction.1 intervention

Trial outcomes

Primary outcomes

1

Stress urinary incontinence (SUI).

Time frame
1 year after surgery.
2

Urgency urinary incontinence (UUI)

Time frame
1 year after surgery

Secondary outcomes

1

Incontinence severity

Time frame
1 year after surgery
2

Patient's satisfaction with the procedure.

Time frame
1 year after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hospital Universitari Vall d'Hebron Research Institute

Lead sponsor

University Hospital Virgen de la Arrixaca, Murcia

Collaborator

Hospital Materno-Infantil de Canarias. Las Palmas de Gran Canaria. Spain

Collaborator

Hospital de l'Esperit Sant

Collaborator

Consorci Sanitari de Terrassa

Collaborator

This trial is not recruiting at the moment. You can still explore other options: